Is NCT07089615 recruiting in Oak Lawn, IL?

Yes, NCT07089615 is currently recruiting participants at its Oak Lawn, IL location. This colonic polyps clinical trial is actively enrolling qualified participants.

How do I join the colonic polyps clinical trial in Oak Lawn?

To join this clinical trial in Oak Lawn, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Oak Lawn clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Colonic Polyps Clinical Trial in Oak Lawn, IL

About This Colonic Polyps Study in Oak Lawn

Note: This is the same study protocol as NCT04607746 with slight changes to how the videos will be read and a 2nd generation capsule is being studied. The purpose of this study is to evaluate the safety and effectiveness of CapsoCam® Colon (CV-3) endoscope system for the detection of colonic polyps and to show that AI-based CADe improves the polyp-detection accuracy and efficiency of capsule video readers. It will use colonoscopy results as a reference. The participant will: 1. prep for and swallow a study capsule and then 2. prep for and undergo a colonoscopy either the following day or 3-6 weeks later

Sponsor: Capso Vision, Inc.

Who Can Participate

Inclusion Criteria

45-75 years of age

Committed to undergo a colonoscopy.

Choose to participate and must have signed the IRB-approved informed consent document and agreed to release colonoscopy images and results report to Sponsor

Exclusion Criteria

Colonoscopy or CT-colonography within the past 5 years that demonstrated no polyps

Has contraindication for capsule endoscopy or colonoscopy

Subject is suspected or diagnosed with familial adenomatous polyposis, hereditary non polyposis colon cancer, or any high-risk genetic syndrome

Subject is suspected or diagnosed with inflammatory bowel disease such as ulcerative colitis or Crohn's disease

History of incomplete colonoscopy

Type I or uncontrolled II Diabetes (Uncontrolled defined as HbA1C\>6.4 within the past 3 months and/or with history of constipation or gastroparesis).

Impaired cardiac function assessed as greater than NYHA Class II

History of small- or large-bowel obstructive condition

Known history of swallowing disorder, and/or ischemic bowel disease neuropathies and/or radiation enteritis

Known history of NSAID enteropathy and stricture resulting from taking NSAIDs on a regular basis that, in the opinion of the Investigator, would put the subject at greater risk for capsule endoscope retention

Known allergy to ingredients used in bowel preparation and boosters

Daily and/or regular narcotic use

Decompensated cirrhosis

Prior abdominal radiation therapy

Diagnosis of anorexia or bulimia

History of or suspicion of any of the following: strictures, volvulus or intestinal obstruction, or internal hernias or abdominal surgeries that the Investigator believes should exclude the patient from study participation

Known or suspected megacolon

Scheduled to undergo MRI examination within 7 days after ingestion of the capsule

Has known slow gastric-emptying time or confirmed diagnosis of gastroparesis

Pregnant or nursing or of child-bearing potential and does not agree to practice medically acceptable methods of contraception. Women of child bearing potential (WOCBP) must have a negative urine pregnancy test at screening.

Unable to follow or tolerate fasting, bowel preparation, and other study procedures

Any documented medical or psychological condition or significant concurrent illness which, in the Investigator's opinion, would make it unsafe for the subject to participate in this research study or would affect the validity of the study results

Are currently enrolled in an interventional clinical study or currently enrolled in or within the last 30 days, a pharmaceutical clinical study

Chronic constipation as defined by \<3 bowel movements per week, or the use of routine laxatives (other than fiber) to attain regular bowel movements

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Oak Lawn?

Yes, this clinical trial (NCT07089615) has an active research site in Oak Lawn, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colonic Polyps Treatment Options in Oak Lawn, IL

If you're searching for colonic polyps treatment options in Oak Lawn, IL, this clinical trial (NCT07089615) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Oak Lawn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colonic polyps specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colonic polyps clinical trials near you to find additional studies recruiting in your area.

Colonic Polyps Clinical Trial in Oak Lawn, IL

Expert Care in Oak Lawn

IRB Approved

No-Cost Care

Apply for This Oak Lawn Location

Why Participate?

Simple Process